Crizanlizumab: First Approval

Overview of attention for article published in Drugs, January 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 77 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 981 followers.

Crizanlizumab: First Approval. https://t.co/ryb6UpXOpe

Reply Repost Favourite

New article: Crizanlizumab: First Approval. https://t.co/pU6UMj4v6I #MF #myelofibrosis #hematology

Reply Repost Favourite